|
|
| | Lazertinib Basic information |
| Product Name: | Lazertinib | | Synonyms: | CS-2767;Lazertinib(YH25448,GNS-1480);YH 25448;YH25448;GNS-1480;GNS1480;GNS1480;GNS-1480;LAZERTINIB; YH-25448; YH 25448; YH25448; GNS-1480; GNS 1480; GNS1480.;Lazertinib;YH25448 | | CAS: | 1903008-80-9 | | MF: | C30H34N8O3 | | MW: | 554.64 | | EINECS: | | | Product Categories: | APIs | | Mol File: | 1903008-80-9.mol |  |
| | Lazertinib Chemical Properties |
| density | 1.27±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:6.5(Max Conc. mg/mL);11.72(Max Conc. mM) | | form | A solid | | pka | 12.39±0.70(Predicted) |
| | Lazertinib Usage And Synthesis |
| Uses | Lazertinib is used in the preparation of heteroaryl pyrimidinylamine compounds for modulating EGFR mutant kinase activities. EGFR tyrosine-kinase inhibitor. |
| | Lazertinib Preparation Products And Raw materials |
|